Autoimmunity and Antibodies to Interferons in Patients with Carcinoid Tumors—Clinical Consequences

Journal of Interferon Research

Volumn 14, Issue 4, 1994, Pages 215-216

  Oberg K E ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; INTERFERON ANTIBODY; NEUTRALIZING ANTIBODY; RECOMBINANT ALPHA INTERFERON;

ANTIBODY DETECTION; ANTIBODY RESPONSE; AUTOIMMUNITY; CARCINOID; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG RESPONSE; HUMAN; HYPOTHYROIDISM; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL; SIDE EFFECT; THYROIDITIS; THYROTOXICOSIS;

ANTIBODY FORMATION; AUTOIMMUNE DISEASES; CARCINOID TUMOR; FEMALE; HUMAN; INTERFERON ALFA-2A; INTERFERON ALFA-2B; INTERFERON-ALPHA; MALE; MIDDLE AGE;

EID: 0028026919     PISSN: 01978357     EISSN: 15577465     Source Type: Journal    
DOI: 10.1089/jir.1994.14.215     Document Type: Article

References (1)

1. RÖNNBLOM, L.E., ALM, G.V., and ÖBERG, K.E. (1991). Autoimmunity after alpha-interferon therapy for malignant carcinoid tumors. Ann. Int. Med. 115, 178–183.